Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1 8Phase 1/2 4Phase EARLY_PHASE1 2Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 2

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × HhAntag691 × Clear all
NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed
27 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT02436408 2021-10-28

VISORB

University of Michigan Rogel Cancer Center

Phase 4 Completed
35 enrolled 9 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡